Similar Articles
Recent advances in stem cell-based therapeutics in ophthalmology
Büşra Candan Balkan, Oytun Erbaş
DOI: 10.5606/fng.btd.2023.137
Comparative analysis of the 7th and 8th TNM staging with long-term outcomes in non-small cell lung cancer
Halit Yardımcı, Recep Ustaalioğlu, Bülent Aydemir, Mehmet Yıldırım, Tamer Okay
DOI: 10.5606/fng.btd.2024.140
The effect of version update in radiotherapy treatment planning system on early-stage glottic laryngeal cancer plans
Nilsu Çini, Beyhan Ceylaner Bıçakçı
DOI: 10.5606/fng.btd.2024.141
Genetically engineered mice models and generating glioblastoma multiforme in the brain
Yasin Polat, Oytun Erbaş
DOI: 10.5606/fng.btd.2024.147
Innovations in dentistry: Mesenchymal stem cell therapies
Nefise Alıcı, Oytun Erbaş
DOI: 10.5606/fng.btd.2024.152
Balancing Act: NRF2's contradictory roles in cancer progression and therapy
Alper Demirezen, Oytun Erbaş
DOI: 10.5606/fng.btd.2024.160
Perspectives on the use of stem cells for autism treatment
Güler Dilara Solmaz, Oytun Erbaş
DOI: 10.5606/fng.btd.2024.163
Microbial influences on cancer: Mechanisms and implications
Gökçen Kılınç, Oytun Erbaş
DOI: 10.5606/fng.btd.2024.161
Expression profiles and regulatory crosstalk of lncRNA HOTAIR and miR-29b-3p across breast cancer subtypes: Implications for tumor progression and therapy resistance
Şara Alagöz, Şehnaz Doğa Kök
DOI: 10.5606/fng.btd.2025.189
The ZEB1-AS1/ZEB1 axis promotes epithelial-mesenchymal transition in prostate cancer
Gamze Nur Öter, Merve Nur Işık Kolukısaoğlu, İlknur Bingül, Servet Tunoğlu, Canan Küçükgergin
DOI: 10.5606/fng.btd.2025.192
Subtype-specific lncRNA signatures: MALAT1 and XIST in breast cancer
Pelin Soytürk, Miray Acer
DOI: 10.5606/fng.btd.2025.206
Exosomes in cancer progression: Orchestrators of EMT, pre-metastatic niches, and therapy resistance
Irem Yalim Camci, Arzu Aysan, Nursah Ersezen, Iremnur Caglayan
DOI: 10.5606/fng.btd.2025.199